Joanna Metzner-Sadurski: Cancer Detection Study – Clinical Trial AOI2102 
Joanna Metzner-Sadurski/LinkedIn

Joanna Metzner-Sadurski: Cancer Detection Study – Clinical Trial AOI2102 

Joanna Metzner-Sadurski, Medical Doctor at Self Regional Healthcare and Executive Director of Oncology101.org, shared a post on LinkedIn:

Cancer Detection Study – Clinical Trial AOI2102 

We all wish there were one simple blood test to detect cancer early – before symptoms, before spread, before treatment becomes complex.

The AOI2102 trial is studying whether a blood-based test can safely and accurately detect early cancer signals. Early detection saves lives – but new tests must be carefully evaluated to ensure they are accurate, responsible, and truly beneficial for patients.

Bringing clinical trials into community oncology helps break barriers – improving access, reducing travel burden, and building trust close to home. Research belongs in the community.

At Oncology101.org, we are committed to explaining clinical trials like this in clear, plain language, so patients can understand their options and make informed decisions.”

Joanna Metzner-Sadurski: Cancer Detection Study – Clinical Trial AOI2102 

Other OncoDaily articles featuring Joanna Metzner-Sadurski.